ClinicalTrials.gg
CompletedNCT01042145Updated Sep 15, 2014Results posted

Community Care for Croup (RCT)

A Phase 4 interventional study of Prednisone and Dexamethasone in Croup, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 1 Year to 8 Years. Per ClinicalTrials.gov, last updated 2014-09-15.

Sponsored by Washington University School of Medicine · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
87
Allocation
Randomized
Ages
1 Year to 8 Years
Sex
All
01

Study summary

This randomized clinical trial was to compare the effectiveness of prednisone 2mg/kg/day for 3 days vs. dexamethasone 0.6mg/kg for 1 day for treatment of children with mild or moderate croup. It was conducted in a practice-based research network of community pediatricians in the St. Louis area. Outcomes included additional health care for croup, duration of symptoms, nights of disturbed sleep, parental stress, missed work days, and adverse events. Our hypothesis was that community-based treatment of children with mild or moderate croup with multiple doses of prednisone is superior to a single dose of dexamethasone.

02

Conditions studied

  • Croup

Browse trials for

Keywords

  • Primary Care
  • Treatment
  • Croup
  • Corticosteroids
  • Prednisone
  • Dexamethasone
  • Randomized trial
03

In context

Croup

18 studies on the registry are indexed under Croup; 2 are open to participants now.

This study's enrollment of 87 is close to the median of 86 across 12 interventional studies indexed under Croup.

Browse Croup studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,803 studies on the registry; 271 are open to participants now.

Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 8 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children aged 1 to 8 years old (not yet reached their 9th birthday), who have croup symptoms for less than or equal to 48 hours and have a physician diagnosis of mild or moderate croup.

Exclusion criteria

Exclusion Criteria:

  • Severe croup or impending respiratory failure;
  • another reason to indicate the need for hospitalization;
  • symptoms or signs to suggest another cause of stridor;
  • active varicella infection;
  • diabetes;
  • known immunodeficiency disease;
  • chronic respiratory disease such as CF (Cystic Fibrosis);
  • prescribed a controller medication or oral for asthma in the past 12 months;
  • a history of TB(tuberculosis) in a household member;
  • treatment for seizures;
  • treatment with epinephrine or oral corticosteroids for this croup episode before enrollment;
  • not accompanied by their legal guardian;
  • the accompanying adult will not be in the same household as the child for the next four days;
  • parent/legal guardian is unavailable for telephone follow-up or does not speak English.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
87 participants (actual)

Study arms

  • Active comparator
    Prednisone

    Prednisone, 2mg/kg for 3 days

    Drug: Prednisone

  • Active comparator
    Dexamethasone

    Dexamethasone, 0.6mg/kg for one day, then placebo for 2 days

    Drug: Dexamethasone

Interventions

06

What researchers measure

Primary outcomes

  1. Additional Health Care

    The primary outcome was the % of participants who had additional health care for croup within 11 days of randomization assessed by self-report. This dichotomous variable was positive if any of the following occurred: office visit, ED visit or hospitalization for croup care.

    Time frame: 11 days

Secondary outcomes

  1. Duration of Croup Symptoms

    Time frame: 12 days

  2. Nights With Disturbed Sleep

    Time frame: 12 days

  3. Parental Stress

    Parental stress due to the child's illness was rated using a 4-point categorical scale (ranging from 3-very stressed to 0-not stressed). We report days until the stress rating was 0.

    Time frame: 12 days

  4. Time Missed From Work

    Time frame: 12 days

  5. Number of Participants With Reported Side Effects

    Time frame: 12 days

07

Results

Posted Sep 15, 2014
Limitations and caveats
Our failure to demonstrate any difference bewteen the two study groups may be due to the small sample size. We were unable to recruit the targeted sample size of 200.

Participant flow

Children were recruited from 10 primary care pediatric practices over two winters: between October 26, 2009 and April 16, 2010; and between September 6, 2010 and April 29, 2011.

Participant flow — Overall Study
MilestonePrednisoneDexamethasone
Started4146
Completed4045
Not completed11

Outcome measures

PrimaryAdditional Health Care

The primary outcome was the % of participants who had additional health care for croup within 11 days of randomization assessed by self-report. This dichotomous variable was positive if any of the following occurred: office visit, ED visit or hospitalization for croup care.

Time frame:
11 days
Reported as:
Number · percentage of participants
Additional Health Care
percentage of participantsPrednisoneDexamethasone
Additional Health Care7 (1.5 to 19.9)2 (0 to 11.5)
Statistical analysis
  • Prednisone vs Dexamethasone · Fisher Exact · p = 0.34
SecondaryDuration of Croup Symptoms
Time frame:
12 days
Reported as:
Mean · days
Duration of Croup Symptoms
daysPrednisoneDexamethasone
Duration of Croup Symptoms2.2 ± 1.32.8 ± 2.7
Statistical analysis
  • Prednisone vs Dexamethasone · Wilcoxon (Mann-Whitney) · p = 0.63
SecondaryNights With Disturbed Sleep
Time frame:
12 days
Reported as:
Mean · nights
Nights With Disturbed Sleep
nightsPrednisoneDexamethasone
Nights With Disturbed Sleep1.21 ± 2.690.68 ± 1.55
SecondaryParental Stress

Parental stress due to the child's illness was rated using a 4-point categorical scale (ranging from 3-very stressed to 0-not stressed). We report days until the stress rating was 0.

Time frame:
12 days
Reported as:
Mean · days
Parental Stress
daysPrednisoneDexamethasone
Parental Stress1.56 ± 2.691.39 ± 1.08
Statistical analysis
  • Prednisone vs Dexamethasone · Wilcoxon (Mann-Whitney) · p = 0.51
SecondaryTime Missed From Work
Time frame:
12 days
Reported as:
Mean · Hours
Time Missed From Work
HoursPrednisoneDexamethasone
Time Missed From Work3.79 ± 7.404.06 ± 5.54
Statistical analysis
  • Prednisone vs Dexamethasone · Wilcoxon (Mann-Whitney) · p = 0.24
SecondaryNumber of Participants With Reported Side Effects
Time frame:
12 days
Reported as:
Number · percentage of participants
Number of Participants With Reported Side Effects
percentage of participantsPrednisoneDexamethasone
Number of Participants With Reported Side Effects2624
Statistical analysis
  • Prednisone vs Dexamethasone · Fisher Exact · p = 1.0

Adverse events

Collected over 28 days. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Prednisone—0/41 (0%)0/41 (0%)
Dexamethasone—0/46 (0%)0/46 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)PrednisoneDexamethasoneTotal
<=18 years414687
Between 18 and 65 years000
>=65 years000
Age, Continuous
Age, Continuous(years)PrednisoneDexamethasoneTotal
Mean2.67 ± 1.433.11 ± 1.582.9 ± 1.5
Sex: Female, Male
Sex: Female, Male(Participants)PrednisoneDexamethasoneTotal
Female131831
Male282856
Region of Enrollment
Region of Enrollment(participants)PrednisoneDexamethasoneTotal
United States414687
08

Study locations

1 site
  • Washington University School of Medicine
    St. Louis, Missouri 63110, United States
09

References and documents

Publications

  • Garbutt JM, Conlon B, Sterkel R, Baty J, Schechtman KB, Mandrell K, Leege E, Gentry S, Stunk RC. The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial. Clin Pediatr (Phila). 2013 Nov;52(11):1014-21. doi: 10.1177/0009922813504823. Epub 2013 Oct 3. PubMed 24092872 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01042145
Collaborators
Washington University Pediatric and Adolescent Ambulatory Research Consortium
Responsible party
Jane Garbutt, MD (Associate Professor, Washington University School of Medicine) — Principal investigator
First posted
Jan 5, 2010
Start date
Oct 2009
Primary completion
Jun 2011
Completion
Jun 2011
Results posted
Sep 15, 2014
Last update
Sep 15, 2014

Study contacts

Jane M Garbutt, MB, ChB
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Prednisone · Dexamethasone

Start the discussion